Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study-Reference-Cited by-同舟云学术

Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study

Published:2021-11 Issue: Volume:Volume 15 Page:2417-2429
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Stephenson Judith J^ORCID,Gable Jonathon Colby,Zincavage Rebekah,Price Gregory L,Churchill Collin,Zhu Emily,Stenger Keri,Singhal Mukul,Nepal Bal,Grabner Michael^ORCID,Fisch Michael J^ORCID,Debono David^ORCID,Geschwender Amy R,Cuyun Carter Gebra

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference36 articles.

1. Cancer statistics, 2020

2. Extending Survival with Chemotherapy in Metastatic Breast Cancer

3. National Cancer Institute. SEER cancer stat facts: female breast cancer. Available from: https://seer.cancer.gov/statfacts/html/breast.html. Accessed August 17, 2021.

4. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States

5. The American Cancer Society medical and editorial content team. Treatment of Stage IV (Metastatic) Breast Cancer. American Cancer Society; 2020. Available from: https://www.cancer.org/cancer/breast-cancer/treatment/treatment-of-breast-cancer-by-stage/treatment-of-stage-iv-advanced-breast-cancer.html. Accessed August 25, 2020.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study;Cancers;2023-01-03

2. Mapping the experiences of people with advanced cancer across multiple cancer types—a scoping review;Journal of Cancer Survivorship;2022-09-30